SeaStar Medical to Report Q3 Results Nov. 11
The commercial-stage healthcare company will release third quarter financial results and host a webcast and conference call on the same day.
Updated on Nov. 4, 2026 in Corporate Finance
SeaStar Medical Holding Corporation (Nasdaq: ICU) will report its third quarter financial results on November 11, 2026, after market close. The company will host a webcast and conference call the same day at 4:30 p.m. ET.
Why it matters
The quarterly report and live call give investors and observers a scheduled look at the performance of a company whose lead product, QUELIMMUNE, was approved by the FDA in 2024 for pediatric acute kidney injury due to sepsis. Preregistration is required to attend the live call.
The earnings webcast and call begin at 4:30 p.m. ET (2:30 p.m. MT) on November 11, 2026, with a replay available at 7:30 p.m. ET that evening. The financial figures for the quarter have not yet been disclosed, so market reaction cannot be measured until then.
The players
SeaStar Medical Holding Corporation
A commercial-stage healthcare company trading on Nasdaq under the symbol ICU, known for its QUELIMMUNE therapy for pediatric acute kidney injury.
The details
SeaStar Medical Holding Corporation, a commercial-stage healthcare company trading on Nasdaq under the symbol ICU, announced it will release its third quarter results after market close. Participants must preregister to join the live call, and the company's Selective Cytopheretic Device therapy has received Breakthrough Device Designation for seven therapeutic indications.
Timeline
November 11, 2026: Third quarter results released after market close.
November 11, 2026, 4:30 p.m. ET: Webcast and conference call begin.
November 11, 2026, 7:30 p.m. ET: Replay of the call becomes available.
Corporate Trajectory
The scheduled third quarter report arrives after the FDA's 2024 approval of QUELIMMUNE, the only approved product for life-threatening pediatric acute kidney injury due to sepsis. Investors will use the November 11 results to assess how the company has progressed since that approval.
Shareholders and prospective investors can use the November 11 results and call to evaluate the company's quarterly performance before making portfolio decisions. Participants who want to join the live call must preregister in advance.
The takeaway
Investors who follow SeaStar Medical should mark November 11, 2026 on their calendars and preregister for the call if they want to participate live. Reviewing the replay afterward offers another way to evaluate the results.
What happens next
SeaStar Medical will hold its webcast and conference call on November 11, 2026 at 4:30 p.m. ET, with a replay available at 7:30 p.m. ET that evening.
Further reading
For more on how companies report and analyze quarterly results, explore Corporate Finance coverage in Denver.
More information
Visit the SeaStar Medical company website for details on the earnings call and company updates.
Source note: This article includes information reported by The Manila times.
